Journal Information
Vol. 42. Issue 2.
Pages 194 (April - June 2020)
Vol. 42. Issue 2.
Pages 194 (April - June 2020)
ERRATUM
Open Access
Erratum on “Non-indolent mantle cell lymphoma at a single public hospital in Brazil: real world first-line treatment cohort study data”
Visits
3150
Sergio Augusto Buzian Brasil
Corresponding author
sbrasil62@gmail.com

Corresponding author. Rua Guaraciara n° 12, Planalto Paulista, CEP: 04082040, São Paulo, SP, Brazil
, Carolina Colaço, Tomas Barrese, Roberto P. Paes, Cristina Bortolheiro, Rodolfo Delfini Cançado
Irmandade da Santa Casa de Misericórdia de São Paulo, São Paulo, SP, Brazil
Related content
Sergio Augusto Buzian Brasil, Carolina Colaço, Tomas Barrese, Roberto P. Paes, Cristina Bortolheiro, Rodolfo Delfini Cançado
This item has received

Under a Creative Commons license
Article information
Full Text

In the article “Non-indolent mantle cell lymphoma at a single public hospital in Brazil: real world first-line treatment cohort study data”,with DOI number: http://dx.doi.org/10.1016/j.htct.2018.12.003, published in Hematol Transfus Cell Ther. 2020;42(1):93–97, Figure 2 is duplicated, therefore, where it reads:

“The SCG and NSCG overall survival were 12 months and 9.6 months, respectively, and these data were not statistically significant (Figures 2 and 3).”

It should read:

“The SCG and NSCG overall survival were 12 months and 9.6 months, respectively, and these data were not statistically significant (Figure 2)”.

And where it reads:

“In comparison, the SCG and NSCG overall survival results were not statistically significant, which means that with the disposable chemotherapy armamentarium, whatever efforts we make, the results are quite the same, regardless of patient fitness or age (Figure 3).”

It should read:

“In comparison, the SCG and NSCG overall survival results were not statistically significant, which means that with the disposable chemotherapy armamentarium, whatever efforts we make, the results are quite the same, regardless of patient fitness or age (Figure 2).”

Copyright © 2019. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular
Download PDF
Idiomas
Hematology, Transfusion and Cell Therapy
Article options
Tools